Applied Nanoscience Comments on Trading Activity and Share Volume
CARLSBAD, CA--(Marketwire - April 28, 2009) -
Highlighted Links |
Applied Nanoscience, Inc. |
MacReport Media Publishing |
ANI's NanoFense formulation has already been validated at well-known BSL-3 laboratories to be highly effective against the avian influenza simulant strain H9N2, the Human Influenza A virus as well as Haemophilus influenzae (H-flu). According to an independent virologist familiar with the technology and past testing, it is highly probable that the NanoFense formulation will be similarly effective against the current swine influenza strain A/H1N1.
About ANI
ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products to customers worldwide and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential in consumer market segments.
For further information about Applied Nanoscience Inc., please visit: www.appliednanoscience.com
Safe Harbor Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.
Contact:
Philippe Niemetz
800-477-7570 or 212-344-6464
p.niemetz@panconsultants.com
Investor Relations
PAN Consultants Ltd.